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Summary: Fourteen laboratories participated in an exteraal quality control survey (EQCS) for antithyroglo-
bulin- and antirnicrosomal-antibody determination. Seventeen frozen serum samples from individuals suffer-
ing from various thyroid diseases were dispatched by mail. Different test Systems were used by the participants
including the haemagglutination test, radioimmunoassay (RIA), enzyme immunoassay (ELISA) and immu-
nofluorescence test. The different test results of each participant were sized and could be compared by giving
place numbers to each test result. Inter-laboratory quality control was performed by evaluation of a rank
correlation coefficient. There was close agreement between the haemagglutination test results of antimicroso-
mal antibody determination with different test kits, and these tests showed good precision. Antithyroglobulin
antibody titers from the two haemagglutination test-kits used, however, were not directly comparable. When
sized by place numbers, antithyroglobulin antibody results from haemagglutination test, RIA and ELISA
were in close agreement. The least correspondence was shown by the immunofluorescence test, in the antithy-
roglobulin antibody determination.
This EQCS demonstrates'the necessity of international standardisation and the use of test Systems which allow
quantitative determination of antithyroglobulin- and antimicrosomal-antibody.
Erster Ringversuch zur Qualitätskontrolle der Bestimmung von Thyreoglobulin- und mikrosomalen
Antikörpern
Zusammenfassung: An einem ersten Ringversuch zur Qualitätskontrolle der Bestimmung von Thyreoglobu-
lin- und mikrosomalen Antikörpern im Serum nahmen 14 Laboratorien teil. Siebzehn Serumproben von
Patienten mit definierten Schilddrüsenerkrankungen wurden verschickt. Die hauptsächlich im Handel befind-
lichen Testsysteme (Hämagglutinationsteste, Radioimmunoassays, Enzymimmunoassays, Immunfluoreszenz-
Teste) und nur wenige eigen entwickelte wurden verwendet. Da die Testsysteme semiquantitative bzw. quali-
tative Ergebnisse lieferten und deshalb nicht direkt vergleichbar waren, wurden die Testergebnisse der ein-
zelnen Laboratorien nach Platzziffern geordnet. Zur Präzisionskontrolle der einzelnen Testkits wurde ein
Räng-Korrelationskoeffizient errechnet.
Die beste Übereinstimmung und Präzision erzielten die Hämagglutinationsteste zur Bestimmung der mikro-
somalen Antikörper. Bei der Bestimmung der Thyreoglobulin-Antikörper wären die Titer der zwei ver-
schiedenen, kommerziell erhältlichen Hämagglutinationsteste unterschiedlich und nicht direkt vergleichbar.
Die radioimmunologischen und enzyinimmunologischen Testverfahren waren nach Verteilung von Platzzif-
fern für die einzelnen Serumproben größenmäßig vergleichbar mit den Hämagglutinationstesten. Die Präzi-
sion der Thyreoglobulin-Antikörper-Test-Kits war insgesamt schlechter als die der für mikrosomale Anti-
körper, Die größten Schwankungen zeigten die verschiedenen Immunfluoreszenztest-Kits. Diese Untersu-
chung zeigt die Notwendigkeit, die einzelnen Testsysteme mehr zu standardisieren und Bestimmungsmetho-
den zu entwickeln, die eine bessere Quantifizierung der Ergebnisse ermöglichen.
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Introduction
Autoantibodies against various components of the
thyroid gland have gained in importance, especially
with reference to the aetiology (l -4) and diagnosis
(5, 6) of various diseases of the thyroid gland. This
increasing importance is due not least to more sensi-
tive test Systems, which were developed during the
last few years. The following applications of autoan-
tibody determination have attracted special atten-
tion:
1) Differentiation between Graves* disease and au-
tonomous adenomata and multifocal aütonomy,
respectively;
2) follow-up of Graves* disease under medical treat-
ment;
3) investigation of the role that autoantibodies may
play in the differentiation between immunogenic
thyroid disorders and simple endemic goiter (7);
4) investigation bf the natural history pf Hashimo-
ro's disease with special regard to the develop-
ment of hypothyroidism (8).
Basically four different Systems are available for the
determination of antithyroglobulin- and antimicro-
somal-antibody: haemagglutination tests, radio-li-
gand-assays, enzyme immunoassays and finally im-
munofluorescence tests. The aim of this first external
quality control survey was to determine whether the
results of these different determinations are compar-
able. The survey was initiated by the German Endo-
crine Society, Thyroid Section. Fourteen German la-
boratories took part, some of them using more than
one of the methods cited above.
Materials and Methods
Samples
Serum samples were drawn from 17 different patients with var-
ious diseases of the thyroid (tab. 1). It should be noted that the
diagnoses were made according to clinical and functional criteria
only, i.e. none of the antibodies to be tested underlay the diagno-
sis given in table l, except in Hashimoto*s disease (serum no. 3, 6,
16). The frozen serum samples were dispatched by mail, and the
laboratories participating only knew the numbers of the serum
samples.
Evaluat ion
Determination of antithyroglobulin antibodies
The following test Systems were used:
1) Haemagglutination test (Fujizoki distributed by Mast): 6 par-
ticipants.
2) Haemagglutination test (Wellcome): 5 participants.
3) Radioligand assay (CIS/IDW): 3 participants.
4) Radioligand assay (Serono): 2 participants.
5) Immunofluorescence test (Mast, Proma, Travenol, own meth*
öd): each with l participant.
6) Enzyme immunoassay (own methöd): l participant.
In view of the different methodologies (and the fact that the re-
sults were qualitative, semiquantitative or quantitative) a stanr
dardized evaluation of the data was extremely difficult. Therefore
we evaluated the results obtained by immunofluorescence tests
separately ffom those obtained by haemagglutination tests. In ad-
dition, we tried to obtain an overall evaluation äs follpws: The
different test results of each participant were sized arid a place
number was given to each test result. Furthermore a rank correla-
tion analysis (according to Speärman (9)) was applied to the ranks
obtained from the test results for evaluation of inter-laboratory
quality control.
Distribution of place numbers
The results obtained by each of the participants using their special
methöd were sized and numbered; i.e. place number l was given
to the highest values of antithyroglobulin antibody and so forth. If
the same result was reported more than once, the appröpriate
place number was given to each of these results, omitting the foU
lowing place numbers. An example: Participant no. 2 obtained the
highest antithyroglobulin antibody titer (1:25600) from sample
no. 5 and 6; these received place number l, place no. 2 was omit-
ted. The next lower titer (1:6400) was obtained from sample no.
3, which received place no. 3 and so forth. The negative results
were evaluated separately: To each negative result place nö. 17
was given.
Distribution of ranks (used in rank correlation analysis)
Basically the distribution of ranks was done äs described above.
The treatment of ties, however, was different: The rank given to
equal results was computed äs the mean value of the ranks given
to each of the equal results. In the example above the rank 1.5 (=
(l+2)/2) was given to the two highest results. The same methöd
was also applied to negative results. If, for example, four negative
results were reported, to each of the^se results rank 15.5 (=
Tab. 1. Characterization of samples.
Sample Diagnosis*
no.
1 Graves' disease, euthyroid
2 Graves* disease, euthyroid for 20 years
3 Hashimoto** disease
4 Thyrotoxicosis without eye signs
5 Thyrotoxieosis without eye sigiis
6 Hashimoto'* disease, euthyroid
7 Graves* disease
8 Subacute thyroiditis
9 Graves* disease, euthyroid
10 Graves' disease
11 Euthyroid Graves' disease
12 Graves* disease
13 Graues* disease, euthyroid
14 Sample 13+100 [ig/l thyroglobulin Standard
15 Graves* disease
16 Hashimoto'* disease
17 ' Sample 13-1-300 g/l thyroglobulin Standard
* Diagnoses were received from clinical and laboratory findings,
antibody titers were not used for diagnosis except in Hashimo-
to** thyroiditis. **
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(14+15 +16+17)/4) was given. Theoretically if 17 equal results
had been obtained from one laboratory, rank 9 would have been
given to each of them. A rank correlation analysis (9) was done
with the 17 results of each participant. The reference quantities R$
were computed using the following formula:
RJ = (m + Π2 + ... rin)/17.
ry: rank given to results of participant j for sample i;
i.e. the mean rank of participants for a particular sample was ta-
ken s reference quantity. The rank correlation coefficient TJ of
participant j was computed by
17
6 Σ (ΓΗ
In this way, an inter-laboratory comparison of the results was pos-
sible.
Results obtained by the haemagglutination test were evaluated
searately from those obtained by the immunofluorescence test.





The absolute antibody titers obtained by the two
different test kits (Fujizoki, Wellcome) could not be
compared. We therefore set the highest titer ob-
tained by the Fujizoki (1:409600) equal to the high-
est titer obtained by the Wellcome kit (1:5120). The
next lower titers were treated in the same way and so
on. As one rnay see in figure l the results obtained
by the two different test kits can be compared by this
method fairly well. There is, however, one remarka-
ble difference: The samples with very low titers are
assessed s negative rnore often by the Wellcome kit
than by the kit from Fujizoki. The results obtained
by haemagglutination test did not depend on the two
thyroglobulin concentrations (100 μ§/1, 300 μg/l),
which were added to the samples 13 to produce sam-
ples 14 and 17.
Immunofluorescence test
The immunofluorescence test naturally gives less dif-
ferentiation. Figure 2 shows that 14 out of the 17
samples were determined either positive or negative
by the different participants. The results of samle 13
and 17 demonstrate the dependence on the high thy-
roglobulin concentration of the heterologous immu-
nofluorescence tests. The concentration antithyro-
globulin antibody in sample 17 is assessed s nega-
tive by two participants, whereas sample 13 is as-
sessed s positive by all four participants.










































































































































Fig. 1. Antithyroglobulin antibody titers obtained by haemagglutination test of all serum samples, titers from Fujizoki (D, n = 6) are
given on the left, titers from Wellcome (O, n = 5) on the right Ordinate. Numbers inside the Symbols represent the numbers given
to the different participants.
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Fig. 2. Antithyroglobulin antibody results obtained from immunofluorescence test. Qualitative values from Mast, Pfofna and the own
levels are given on the left, semiquantitative values from Travenol on the right Ordinate.
D Proma (8) Δ Mast (8) O Travenol (10) O Own method (15)
the participants yielded identical results, exeept for
Evaluation of the place numbers sample NQS ?? g and 9 Jhe ̂ ^ of these three
Place numbers were distributed to each result re- samples show the greatest differences: whereas
gardless of whetHer it was determined by RIA, ELI- about half the participants ssessed these samples s
SA, immunofluorescence test or haemagglutination negative, the rest ssessed these samples s positive,
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Fig. 3. Diagram of place numbers from antithyroglobulin antibody values. The numbers inside the symbols represent the number given
to the different participants.
DFujizoki O Wellcome Δ CIS-IDW O Serono O Own method ELISA,
immuno fluorescence test [] Travenol, Proma, Own method () Mast > i
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Rank correlation analysis (Spearman)
High rank correlation coefficients are yielded by the
results of the haemagglutination tests, except for
participant no. 9. A slightly lower rank correlation
coefficient was yielded by radioimmunological meth-




The titers obtained by haemagglutination test Well-
come are directly comparable to those obtained by
haemagglutination test Fujizoki. The coincidence is
fairly good (fig. 4), except for the results from sam-
ples 6, 8 and 9 which were assessed äs markedly pos-
itive by haemagglutination test Fujizoki, whereas by
haemagglutination test Wellcome the results were
more often assessed äs negative.
Immunofluorescence test
The resülts obtained by immunofluorescence test
coincide fairly well (except for two samples which
are assessed äs negative äs well äs positive). The cor-
respondence of these results was markedly better,
compared with the immunofluorescence test results
of the antithyroglobulin antibodies (fig. 5).
Tab. 2. Rank correlation coefficient for antithyroglobulin anti-
body (all participants). If r| ̂  0.564 there is no linear
correlation between the ranks of participant no. i and the



























































































































Fig. 4. Diagram of antimicrosomal antibody titers from haemagglutination test (Fuji2oki, Wellcome). Numbers inside the Symbols repre-
sent the numbers given to the different participants.
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Fig. 5. Diagram of the results obtained by immunofluorescencje test for antimicrosomal antibody. Qualitative values (Proma, Mast, own
method) are given on the left, semiquantitative values (Tfavenol) on the right Ordinate.
D Proma (8) Δ Mast (8) O Travenol (10) O Own method (15)
Rank correlation analysis
The rank correl iion coefficients (tab. 3) of the par-
ticipants using haemagglutination test are all
markedly high. Though the coefficients of those par-
ticipants using immunofluorescence test are lower
they are still significant on the 1% leVel.





















































The inter-laboratory test results of the antimicroso-
mal antibody determinations were in good corre-
spondence; the titers yielded by the two haemagglu^
tination test kits sed can be compared directly.
Furthermore the results obtained by immunofluores^ -
cence test show good agreement with those obtained
by haemagglutination test.
The results of antithyroglobuliii antibodies show
greater diffefences. The absolute antibody titers ob-
tained by the two different haemagglutination test
kits (Fujizoki, Wellcome) eould not be compared di-
rectly; however, they were rh de, comparable by set-
ting the highest titer (1:409600) of the Fujizoki as-
say equal to the highest values (1:5120) of the Well-
come assay and so on for the next lowef titers.
Whereas haemagglutination test, RIA and ELISA
were not disturbed by thyroglobulin added to sample
no. 13, the heterologous immunofluorescence test
kits (Mast, Proma, Travenol) g ve lower or negative
results when thyroglobulin was added (sample 14,
17).
The rank correlation coefficient was best in haemag-
glutination test kits; worse but still significant coeffi-
cients were obtained with immunofluorescence test
kits. The use of the rank correlation analysis, howev-
er, needs some further explaiiations:
1) The method used by most of the participants is
haemagglutination test (11 paftieijpants), whereas 7
participants used radioimmunologicai methods and
J. Clin. Chem. Clin. Biochem. / Vol. 21, 1983 / No. 6
Gärtner, Hörn, König and Schatz: External quality survey for antithyroid antibodies 379
only 4 immunofluorescence tests. It is obvious that
the mean value of the ranks distributed to each of
the results is biased by the method with the highest
number of participants (i.e. haemagglutination test),
Therefore the very high rank correlation coefficients
of these participants are mainly due to the fact that
they belong to the strongest group, because the
mean value of ranks served äs the reference quantity
in the correlation analysis.
2) Rank correlation coefficients can only serve äs a
rough method to check the inter-laboratory compar-
ability or deviation. It would be wrong to conclude
that the results yielded by one participant are correct
just because they show a high correlation coefficient.
Furthermore, in external quality control surveys for
assays without a reference method the mean value of
the majority of the participants is not necessarily the
correct result of the parameter under investigation.
It seems to be important to us that there is no inter-
ference of antithyroglobulin antibody in antimicro-
somal antibody assays and vice versa. This is demon-
strated by samples no. 2, 7,11,16 with high positive
antimicrosomal antibody and negative antithyroglo-
bulin antibody titers and sample no. 6 with high anti-
thyroglobulin antibody titer and low (or even nega-
tive) antithyroglobulin antibody titer respectively.
In spite of these encouraging findings there is still
room for improvements, especially in antithyroglo-
bulin antibody test kits. It is desirable to achieve a
better standardization in order to be able to compare
the results obtained by different test kits. This would
be possible, if RIA or ELISA for antithyroglobulin
antibody (10) and antimicrosomal antibody (11)
were used more widely, and international Standards
wefe available to calibrate the different assay Sys-
tems.
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